India is a must-win country for us, will invest in new products: Sanofi MD

Sanofi ranks first among global players in the emerging markets

.French drugmaker Sanofi has stepped up its focus on India with investment in new facilities and introduction of products and therapies for domestic market and export. The multinational pharmaceutical company, headquartered in Paris, is eyeing 9-12 per cent growth across various verticals.

Speaking to Business Standard, N Rajaram, managing director of Sanofi India, said the company was not only working on bringing in new global drugs to India but it was keen on ramping up exports. New products would primarily be in therapy areas — atopic dermatitis, diabetes, and neurological disorder multiple sclerosis.  Sanofi, which operates in India for six decades